nanotech investing Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update 26 March
nanotech investing Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization 25 March
nanotech investing Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results 19 March
